Belfast-based neurologist gave patients drugs with toxic side-effects, tribunal told

Dr Michael Watt had previously worked at the Royal Victoria Hospital in Belfast (Picture: Liam McBurney/PA)
An assessment report into a Belfast-based neurologist found that he repeatedly failed to make correct diagnoses, which led to patients inappropriately being given drugs with âserious and toxic side-effectsâ, a fitness to practise tribunal has heard.
The Medical Practitioners Tribunal Service (MPTS) hearing into Dr Michael Watt was also told that the assessment found his use of âidiosyncratic diagnostic criteriaâ had led to patients receiving unnecessary invasive treatment.
Dr Watt was at the centre of Northern Irelandâs largest ever recall of patients in 2018 when more than 4,000 of his patients attended recall appointments.
A previous MPTS tribunal granted Dr Watt voluntary removal from the medical register.
However, the High Court quashed that ruling due to concerns it was ânot sufficient to protect the publicâ.
The three-person tribunal began its new hearing on Monday, and was told that Dr Watt will not be in attendance but will be legally represented.
Tribunal chairman Neil Dalton asked Dr Wattâs lawyer, Matthew McDonagh, if any of the facts set out in the allegations against his client are admitted.
Mr McDonagh said: âNo, sir. In the absence of Dr Watt no facts are admitted.â
Charles Garside KC, representing the General Medical Council (GMC), told the hearing it is a performance case, rather than a misconduct case.
He said that, after concerns were first raised about Mr Wattâs work in 2016, an assessment was carried out by the GMC in October 2018. He said the four assessors will be called as witnesses during the hearing.
Mr Garside said Dr Watt had been a consultant neurologist at the Royal Victoria Hospital in Belfast but ceased clinical practice in 2017.
He said Dr Watt had co-operated with the GMC assessment and was interviewed three times.
The barrister then said that, conscious of the âconsiderable publicityâ around the case, he would read directly from the summary and recommendations of the assessorsâ report in a number of categories.
He said: âKnowledge, skills and performance, maintaining professional performance â unacceptable.
âAssessment â unacceptable. Clinical management â unacceptable. Operative technical skills â no judgment.
âRecord-keeping â unacceptable. Safety and quality â no judgment.
âRelationships with patients â unacceptable. Working with colleagues â acceptable.â
Continuing to read from the report, he said: âDr Wattâs performance has been found to be deficient. Dr Watt is not fit to practise and should cease practice.
âThe team has come to this conclusion on the following basis: Persistent failure to take adequate histories from patients and carry out clinical examinations.
âPersistent and repeated failure to make correct diagnoses, resulting in patients receiving inappropriate management which included drugs with serious and toxic side-effects.
âUse of idiosyncratic diagnostic criteria, leading to patients receiving unnecessary invasive treatment (epidural blood patches).
âFailure to consider involving specialist neurologist colleagues in management of complex patients.
âFailure to discuss risks and benefits of treatments with patients to allow them to come to informed decisions.
âDr Watt showed little insight during the assessment with regard to any of the above points.
âThe scope of these deficiencies, combined with this lack of insight, led the team to conclude that remediation is unlikely to change Dr Wattâs performance and he should cease practice.â
Mr Garside said the GMCâs case is based solely on the report of the assessors.
He added: âThe GMC submit that if you accept the assessorsâ opinion you should find that Dr Wattâs fitness to practise is currently impaired.â
The tribunal then went into private session at the request of Dr Wattâs lawyer.